Proteomics in discovery of hepatocellular carcinoma biomarkers

被引:0
|
作者
Wu Cheng [1 ]
Li Song-Tao [2 ]
Liu Li-Jie [1 ]
Wang Zhan-Feng
Lu Jun-Hua [3 ]
Liu Bao-Hai [1 ]
Liao Ping [4 ]
Wang Wen-Jing [4 ]
Zhu Liang [1 ]
机构
[1] Second Mil Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200043, Peoples R China
[3] China Sci & Technol Univ, Dept Stat & Finance, Beijing, Peoples R China
[4] Shanghai Municipal Ctr, Dept Publ Hlth & Mol Biol, Shanghai, Peoples R China
关键词
proteomics; biomarker; hepatocellular carcinoma;
D O I
10.1007/s11670-007-0159-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To discover new proteomic biomarkers of hepatocellular carcinoma. Methods: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to discover biomarkers for differentiating hepatocellular carcinoma and chronic liver disease. A population of 50 patients with hepatocellular carcinoma and 33 patients with chronic liver disease was studied. Results: Twelve proteomic biomarkers of hepatocellular carcinoma were detected in this study. Three proteomic biomarkers were highly expressed in hepatocellular carcinoma and nine proteomic biomarkers were highly expressed in chronic liver disease. The most valuable proteomic biomarker with m/z=11498 had no similar diagnostic value as alpha-fetoprotein. Conclusion: Some of the twelve proteomic biomarkers may become new biomarkers of hepatocellular carcinoma.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [1] Proteomics in Discovery of Hepatocellular Carcinoma Biomarkers
    吴诚
    李松涛
    刘丽杰
    王占锋
    卢军华
    刘保海
    廖萍
    王文静
    朱樑
    ChineseJournalofCancerResearch, 2007, (03) : 159 - 164
  • [2] Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics
    Santamaria, Enrique
    Munoz, Javier
    Fernandez-Irigoyen, Joaquin
    Prieto, Jesus
    Corrales, Fernando J.
    LIVER INTERNATIONAL, 2007, 27 (02) : 163 - 173
  • [3] Proteomics for hepatocellular carcinoma marker discovery
    Chignard, N
    Beretta, L
    GASTROENTEROLOGY, 2004, 127 (05) : S120 - S125
  • [4] Comparative proteomics analysis to identify biomarkers of hepatocellular carcinoma
    Yeo, Marie
    Na, Young Mi
    Kim, Dong-Kyu
    Park, Hee Jin
    Lee, Kwang Jae
    Cho, Sung Won
    GASTROENTEROLOGY, 2008, 134 (04) : A466 - A466
  • [5] Comparative proteomics analysis to identify biomarkers of hepatocellular carcinoma
    Cho, S. W.
    Cheong, J. Y.
    Na, Y. M.
    Lee, M. H.
    Kim, D. K.
    Paik, Y. K.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S142 - S142
  • [6] Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics
    Zhao, Yinghua
    Li, Yang
    Liu, Wei
    Xing, Shan
    Wang, Dan
    Chen, Jing
    Sun, Longqin
    Mu, Jinsong
    Liu, Wanli
    Xing, Baocai
    Sun, Wei
    He, Fuchu
    JOURNAL OF PROTEOMICS, 2020, 225
  • [7] Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease
    Zinkin, Noah T.
    Grall, Franck
    Bhaskar, Killimangalam
    Otu, Hasan H.
    Spentzos, Dimitrios
    Kalmowitz, Brett
    Wells, Meghan
    Guerrero, Manuel
    Asara, John M.
    Libermann, Towia A.
    Afdhal, Nezam H.
    CLINICAL CANCER RESEARCH, 2008, 14 (02) : 470 - 477
  • [8] Subcellular Tissue Proteomics of Hepatocellular Carcinoma for Molecular Signature Discovery
    Lee, Yong-Yook
    McKinney, Kimberly Q.
    Ghosh, Sriparna
    Iannitti, David A.
    Martinie, John B.
    Caballes, F. Ryan
    Russo, Mark W.
    Ahrens, William A.
    Lundgren, Deborah H.
    Han, David K.
    Bonkovsky, Herbert L.
    Hwang, Sun-Il
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (11) : 5070 - 5083
  • [9] Proteomics Discovery of Disease Biomarkers
    Ahram, Mamoun
    Petricoin, Emanuel F.
    BIOMARKER INSIGHTS, 2008, 3 : 325 - 333
  • [10] Integrative plasma proteomics identifies novel diagnostic biomarkers in hepatocellular carcinoma
    Zhou, Shuang
    Abe, Yuichi
    Isomura, Hisanori
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    Taguchi, Ayumu
    CANCER SCIENCE, 2023, 114 : 58 - 58